Detalhe da pesquisa
1.
Acute severe ulcerative colitis trials: the past, the present and the future.
Gut
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834296
2.
Ulcerative colitis.
Lancet
; 402(10401): 571-584, 2023 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573077
3.
Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Dig Dis Sci
; 67(3): 1018-1035, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723700
4.
Basket, Umbrella, and Platform Trials: The Potential for Master Protocol-Based Trials in Inflammatory Bowel Disease.
Gastroenterology
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677483
5.
Positioning biologics and new therapies in the management of inflammatory bowel disease.
Curr Opin Gastroenterol
; 35(4): 296-301, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31021925
6.
5-ASAs in Crohn's Disease: Time to Stop the Salicylate?
Dig Dis Sci
; 67(7): 2699-2700, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797441
7.
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials.
Inflamm Bowel Dis
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38862178
8.
Navigating the complexities of drug development for inflammatory bowel disease.
Nat Rev Drug Discov
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38778181
9.
Biomarkers in inflammatory bowel disease: a practical guide.
Therap Adv Gastroenterol
; 17: 17562848241251600, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38737913
10.
JAK inhibitors for inflammatory bowel disease: recent advances.
Frontline Gastroenterol
; 15(1): 59-69, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38487554
11.
Amoebic colitis masquerading as inflammatory bowel disease for a decade.
N Z Med J
; 136(1573): 124-127, 2023 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054464
12.
Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?
Aliment Pharmacol Ther
; 58(7): 659-667, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602530
13.
An update on the safety of long-term vedolizumab use in inflammatory bowel disease.
Expert Opin Drug Saf
; 22(9): 767-776, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37610086
14.
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practice.
Eur J Gastroenterol Hepatol
; 35(11): 1270-1277, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724470
15.
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?
Gastroenterol Hepatol (N Y)
; 19(12): 727-738, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404416
16.
Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease.
J Crohns Colitis
; 17(11): 1882-1891, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220886
17.
Positioning intestinal ultrasound in a UK tertiary centre: significant estimated clinical role and cost savings.
Frontline Gastroenterol
; 14(1): 52-58, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36561789
18.
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?
Frontline Gastroenterol
; 14(4): 312-318, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37409343
19.
Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment.
J Crohns Colitis
; 16(5): 822-834, 2022 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34962991
20.
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study.
Frontline Gastroenterol
; 13(6): 517-523, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250172